Serum CCL18 is predictive for lung disease progression and mortality in systemic sclerosis
Schupp J, Becker M, Günther J, Müller-Quernheim J, Riemekasten G, Prasse A. Serum CCL18 is predictive for lung disease progression and mortality in systemic sclerosis. European Respiratory Journal 2014, 43: 1530-1532. PMID: 24789955, DOI: 10.1183/09031936.00131713.Peer-Reviewed Original Research